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Sumnlill"y 
We used the simian immunodeficiency virus (SIV)/rhesus macaque model to study events that 
underlie  sexual  transmission  of human inununodeficiency virus type  1 (HIV-1).  Four female 
rhesus macaques were inoculated intravaginally with SIVmac251, and then killed 2, 5, 7, and 
9 d  later.  A  technique  that  detected  polymerase chain reaction-amplified  SIV in situ showed 
that the  first  cellular targets for SIV were in the lamina propria of the cervicovaginal mucosa, 
immediately subjacent to the epithelium.  Phenotypic and localization studies demonstrated that 
many of the infected cells  were likely to be dendritic cells.  Within 2 d of inoculation, infected 
cells were identified in the paracortex and subcapsular sinus of the draining internal iliac lymph 
nodes.  Subsequently,  systemic dissemination  of SIV was rapid,  since culturable  virus was de- 
tectable in the blood by day 5. From these results, we present a model for mucosal transmission 
of SIV and HIV-1. 
E 
Pidemic  spread  of human  HIV-1  occurs  primarily  as 
the result of sexual transmission from infected individ- 
uals,  via free virions or cell-associated virus present  in the 
genital secretions. Although the greatest likelihood of HIV-1 
spread is from an infected male during anal or vaginal inter- 
course,  the process is still  not efficient.  It is estimated  that 
from an HIV-l-infected male,  sexual transmission to a fe- 
male with a single contact carries an infectivity rate of 0.3% 
(1).  In comparison, one such sexual exposure to a hepatitis 
B-infected individual  carries an infectivity rate  of 20-30% 
(2).  Defining the mechanism of sexual transmission, namely, 
how HIV-1 trafficks across the mucosal surface and spreads 
to distal  sites,  is important  not only for understanding  the 
pathogenesis of HIV-1 infection, but also for the develop- 
ment of a protective vaccine. 
Characterization of the virus present in acute HIV-1 se- 
roconvertors has yielded infom~ation about the types of vi- 
ruses that are found after sexual transmission.  In a newly in- 
fected  individual,  the  HIV-1  quasispecies  appear  to  be 
extremely" homogeneous, even when the transmitter of that 
virus has a diverse mixture  of genotypes (3).  These studies 
also  demonstrated  that  the  transmitted  virus  often  repre- 
sents  only a  minor variant  of those  viruses  present  in  the 
blood of the transmitter;  similar findings have been seen in 
maternal-fetal  transmission  of HIV-1  (4).  Although  still  a 
minor species,  the  transmitted  variant  is usually present  in 
higher  amounts  in  the  seminal  cells  and  seminal  plasma 
than  in  the  PBMC  and  plasma  of the  transmitters  (4a). 
During sexual transmission, there is also a selection for viral 
phenoty,  pe.  Even when  a transmitter  harbors  a mixture  of 
viral phenotypes, the  newly infected person  usually has a 
nonsyncytium-inducing virus that is macrophage tropic (3, 
5),  although  exceptions  to  this  have  been  noted  (6).  Se- 
quence  analysis of transmitted  variants  has  demonstrated  a 
higher  selective  pressure  on  the  viral  envelope  protein, 
gp120, which governs many aspects of the viral phenotype 
(3,  7-9).  These  findings  point  to a  bottleneck  that selects 
for  particular  viral  variants  during  sexual  transmission.  A 
possible  location for such a bottleneck is the  nmcosal sur- 
face, which poses a formidable barrier to HIV-1  transmis- 
sion (2,  3). 
It is crucial to understand how HIV-1 disseminates  from 
an initial site of infection to generate a large burst of vire- 
mia  during primary, infection.  The initial viremia is subse- 
quently reduced by several orders of magnitude  (10,  11), a 
phenomenon  that  correlates  with  the  appearance  of cell- 
mediated  immunity  (12).  In spite  of this  efficient  control, 
most  individuals  remain  detectably  virmmc,  and  the  con- 
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munosuppression and AIDS (13,  14).  Although numerous 
hypotheses on the  mechanisms of transmission have been 
proposed based on studies of chronically infected humans 
(15-17) or macaques (18-20), to date none has looked di- 
rectly at acutely infected subjects to identify the initial cel- 
lular target and pathway of virus dissemination after expo- 
sure of an intact mucosal epithelium to virus. 
For these reasons, we aimed to study the earliest events 
that follow an intravaginal transmission of virus. To do this 
in HIV-l-infected humans is  nearly impossible, since in- 
fected  patients  generally  do  not  present  until  they  are 
symptomatic,  when  viral  dissemination  has  already  oc- 
curred. Thus, we used the simian immunodeficiency virus 
(SIV) Vrhesus macaque system, the animal model that most 
closely resembles HIV-1 infection in humans (21). In many 
ways,  SlY  and  HIV-1  are  ve  W  similar,  as  are  the  disease 
courses  they  induce  (22,  23).  Using cell-free SIVmac251 
and female rhesus macaques, a model of atraumatic vaginal 
transmission has been established (18). We infected four fe- 
male macaques in this manner, followed by serial killings 
2-9 d  later.  Using in situ  PCIL to  amplify SlY DNA for 
subsequent detection and  immunocytochemistry,,  we  de- 
termined the  location and  phenotype of the  first  cellular 
targets of infection in the cervicovaginal mucosa. We also 
characterized the route and time course of viral spread from 
the genital mucosa to the proximal draining lymph nodes, 
then to the distal lymphatic tissues.  Based on these studies, 
we present a model of mucosal transmission and dissenfina- 
tion of SlY that has relevance to the sexual transmission of 
HIV-1. 
Materials  and Methods 
Animals.  All  animals  used  in  this  study  were  multiparous 
adult female rhesus macaques  (Macaca mulatta)  at the Laboratory 
for  Experimental Medicine and Surgery  in  Primates  (Tuxedo, 
NY).  Before  use,  the  animals  were  negative for  antibodies to 
HIV-2, SIV, type D retrovims, and simian T cell leukemia virus, 
type I. This study protocol was reviewed and approved by the in- 
stitutional animal care and use committee. 
Inoculations.  The virus stock used for this study was SIVmac251 
(23). This cell-flee inoculum was grown in human PBMC (18) from 
a stock obtained from R. C. Desrosiers of the New England R.e- 
gional Primate Research Center (Southborough, MA)  and con- 
tained 103 TCID~, (50% tissue culture infectious doses per nfillili- 
ter)  (24). Inocula were cryopreserved,  and then thawed at 37~ 
immediately before use. 
The animals were immobilized with an intramuscular injection 
of ketamine HCI (10 mg/kg). A human nasal speculum was then 
inserted into the vaginal canal, followed by a pediatric nasogastric 
feeding tube (2.5 mm outer diameter,  8 french).  1 ml of the inoc- 
ulum was then infused with a syringe through the tube over a course 
of "o5 rain. After removal of the tube, the vaginal canal was then 
visually inspected to ensure no trauma was induced by the proce- 
1Abbreviations used in this paper: BCIP, 5 bromo-4-chloro-3-iudolyl  phos- 
phate; LNMC, lymph node mononuclear cells; NBT, nitroblue tetrazo- 
lium: SIV, simian  immunodeficiency  virus; STF, Streck's tissue fixative. 
dure. After removal of the speculum, the monkeys were vertically 
inverted and remained immobilized until the anesthetic  wore off 
in ~45 rain to 1 h. The inoculum remained inside the vaginal ca- 
nal until it was absorbed. 
Control animals consisted  of an uninfected monkey that was 
killed because of amyloidosis of the liver (Rh Co) and an animal 
that was inoculated with the same viral stock that had been heat 
inactivated at 56~  for 2.5  h  (Rh HI).  Inactivation was verified 
by culturing 10 I~I of the inocuhim before  and after heating (see 
below). 
Necropsy and  Tissue Processing.  One animal was killed at each 
time point, 2, 5, 7, and 9 d after inoculation. Animals killed at the 
later time points were bled at the earlier time points (I0 ml whole 
blood; see Table 1), and plasma and PBMC were obtained as de- 
scribed below. Before necropsy,  the animals were again immobi- 
lized with ketamine. Peripheral lymph nodes were obtained bilat- 
erally from the axillary and inguinal regions. A vertical abdominal 
incision was made, and the internal iliac and common iliac lymph 
nodes were removed by dissection  along the internal and com- 
mon iliac blood vessels. A  terminal bleed was  then performed 
through the abdominal aorta, along with an intravenous overdose 
of phenobarbital. Finally, the spleen,  vagina,  cervix,  and uterus 
were removed. 
PBMC  from heparinized whole  blood and splenic  lympho- 
cytes were isolated by Ficoll-Hypaque (Organon Teknika, Dur- 
ham,  NC)  gradient centrifugation as previously described  (25). 
Lymph nodes were dissected, and lymph node mononuclear cells 
(LNMC) were isolated in PBS. The remainder of the nodes and 
spleen, vagina, cervix, and uterus were cut into pieces of"~0.5 ￿ 
1 cm, washed  in PBS, and put into Streck's  tissue fixative (STF; 
Streck Laboratories,  Inc., Omaha, NE) for 1 wk. The tissues were 
then embedded into paraffin using an automated tissue processor, 
under heat  and vacuum pressure.  Tissues from control and test 
animals were processed in an identical manner. 
Virus Isolation.  From the terminal bleeds, 2 X  10  7 PBMC and 
2-5 ￿  107 LNMC were added to 5 ￿  106 CEMx174 cells (26) in 
20 ml oflKPMI 1640 media supplemented with 10% heat-inacti- 
vated FCS, penicillin (250 U/ml), streptomycin (250 p,g/ml), and 
10 mM Hepes.  1 ml plasma and 2 ￿  106 PBMC from preterminal 
time points were cocultured in 1.5 ml supplemented media with 
2  X  106 CEMx174  cells. After  1 wk,  half the  cells and media 
were removed and fresh media were added twice each week for 8 
wk.  The cultures  were monitored for cytopathic effects (syncy- 
tium formation)  and assayed using an immunoassay for SlY gp120 
production as previously described  (27). Briefly, culture supema- 
rants (1:3) were added to a solid phase containing the sheep poly- 
clonal antibody D7369 (Aalto BioReagents, Dublin, Ireland), and 
bound gp120  was  detected  using serum from  an SIV-infected 
macaque, followed by alkaline phosphatase-conjugated  anti-human 
lgG (Accurate  Chemicals,  Westbury, NY) and the AMPAK de- 
tection system (Dako  Diagnostics,  Carpentiera, CA).  All positive 
cultures  had optical densities at 492 nm >1.00 at all time points 
after the third week of culture. All negative cultures  had optical 
densities <0.075, which were equivalent to background levels in 
the assay. Using purified SIVmac239 gp 140, SIVmac 1A 11 gp 140, 
and SIVmac239 gpl30 obtained through the AIDS Research and 
Reference Reagent Program,  National Institute of Allerg  T  and 
Infectious Diseases (NIAID), National Institutes of Health (NIH, 
Bethesda, MD), this assay was determined to be sensitive to <25 
pg of gp 120/ml of supematant. 
PCR and In Situ  PCR.  Genonfic DNA was isolated from STF- 
fixed,  paraffin-embedded blocks  as  follows.  Between 6  and  10 
8-btm sections were cut with a clean, disposable microtome blade 
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samples were deparaffinized twice with 1 ml xylene for 30 min at 
room temperature,  and the xylene was  removed with two  15- 
min washes  of 100% ethanol. After  drying the tissue in a 60~ 
oven for 30  rain, the samples were  digested  in 300  ILl of lysis 
buffer (50  n'flVl Tris,  pH  8.0,  1 n~Vl EDTA, 0.5%  Tween 20) 
containing 200 p-g/ml proteinase  K for 2 h at 55~  The samples 
were extracted  two to  three times  with  1:1  phenol/chlorofoml 
and then two  to  three times with chloroform.  Genomic DNA 
was precipitated  in ethanol overnight at -40~  washed  in 70% 
ethanol, dried,  and resuspended  in water.  Genomic DNA was 
isolated from PBMC by extraction with a guanidinium  isothiocy- 
anate-based  DNA  extraction  kit  (United  States Biochemical 
Corp., Cleveland, OH), following the manufacturer's instructions. 
From 0.2 to 2 ~g of the genonfic DNA in a volume of 5 btl were 
then used in a nested PCR for SIV gag. Outer primers were AS29 
(+): 5'-CGTCTTGTCAGGGAAGAAAGCAGATGAAT-3'  (cor- 
responding to bases 1058-1087 of the SlVmac251  genome), and 
AS30  (-): 5'-CTTCCTCAGTGTGTTTCACTTTCTCTT-3' 
(positions 1338-1312). Inner primers were AS31 (+): 5'-G  AAA- 
ATTAGGCTACGACCCGGCGGAAAG-3' (positions  1089- 
1118),  and AS32:  (-):  5'-TTATAAAGGCTTTTTAAATTT- 
TCT-3'  (positions  1279-1256).  PCR  reaction  mixtures  con- 
tained 10 mM Tris, pH 8.3, 50 mM KC1, t.5 mM MgCI> 2.5 U 
Taq DNA polymerase  (Perkin-Elmer, Emeryville, CA)  and 100 
ng of each  (+) and (-) primer. Cycling conditions were 30 cy- 
cles at 94~  for 15 s, 55~  for 1 min, and 72~  for l  min 45 s, in 
a final volume of 100 I.tl. A 5-p-1 aliquot of the product from the 
outer primers was used in the inner PCR, and the resultant PCR 
product  visualized  as  a  190-bp  product  by  ethidium bromide 
staining after agarose gel electrophoresis.  All blocks were tested at 
least twice in this manner. A random sampling of PCR products 
was sequenced using Sequenase  2.0 (United States Biochemical 
Corp.) to verify that the amplified fragnlent was, in fact, the SIV 
gag gene. 
For in situ PCR, 8-I.tm sections were cut onto a silanized slide 
with a clean, disposable microtome blade. The samples were de- 
paraffinized in xylene and hydrated through graded  alcohols and 
air dried.  After rehydration in PBS, the samples were digested in 
proteinase K  (20  b~g/ml) in lysis buffer (20  mM Tris,  pH  8.0, 
0.5%  SDS) for  45  min to  1 h  at  37~  and the slide was  then 
heated  to  95~  for  1 rain to  inactivate  the  proteinase K.  The 
slides were washed in PBS for 1 min, dehydrated through graded 
alcohols,  and air dried before placement on a  slidecycler  (Coy 
Laboratories,  Detroit, MI) preheated to 82~  Each slide was re- 
hydrated in 40  ILl of a PCR reaction mixture consisting of 10 
mM Tns, pH 8.3,  1.5 mM MgCI2, 0.25  mM dATP, 0.25  mM 
dCTP, 0.25 mM dGTP, 0.14 mM dTTP, t2.9 I~M digoxigenin- 
11-dUTP (Boehringer Mannheim Corp., Indianapolis, IN), and 
50 ng of each primer (AS29 and AS30), preheated to 94~  for 1 
min. Subsequently, 0.75  ILl (5 U/p.l) Taq DNA polymerase  was 
added to initiate the hot-start PCR reaction. The samples were 
covered with a 22 X 40-mm glass coverslip, sealed with nail pol- 
ish, and cycled for 25 cycles of 94~  for 1 min, 56~  for 2 min, 
and 72~  for 2 min. 
After cycling,  the coverslip  was removed, and the slides were 
washed  twice for  5 min in PBS. A  1:l,000 dilution of alkaline 
phosphatase-conjugated antidigoxigenin (Boehringer Mannheim 
Corp.)  in PBS  was added to  the slides, which were then incu- 
bated overnight at 4~  The slides were washed twice with PBS, 
and then incubated for 30 n-fin  with nitroblue tetrazolium (NBT; 
337.5 I.tg/rnl) and 5-bromo-4-chioro-3-indolyl  phosphate  (BCIP; 
175  btg/ml)  in alkaline  phosphatase  buffer (100  m/Vl Tris,  I00 
mM NaCI, 50 mM MgC1  z, pH 9.5)  for 15-30 min at ambient 
temperature in the dark. Slides were then washed in water,  coun- 
terstained  with  fast green,  washed  again,  and  mounted using 
Crystal/Mount (Biomeda, Culver City, CA). Positive cells yielded 
a black nuclear precipitate. 
Controls for the in situ PCR assay included tissue fiom Rah Co 
and Rh HI, tissue from parai]in blocks that were negative by so- 
lution-phase PCR, and serial sections of slides with positive signal 
to which no Taq DNA polymerase  or primer was added,  or the 
use of the HIV-1 primers SK38/SK39 (28) in place of SIV prim- 
ers. More  than 40  control slides were  tested  in parallel  under 
these  conditions, and positive cells were  never detected in any 
sections. Sections in which SIV  + cells were found were confirmed 
as positive by studying more than five sections. 
lmmunohistochemistt  T.  Immunohistochemistry was performed 
using the LSAB, LSAB2, and Doublestain kits (Dako Diagnostics) 
according to the manufacturer's instructions. Sections  were de- 
paraffinized  and rehydrated  through  graded  alcohols  and Tris- 
buffered saline as above. The following antibodies (all from Dako 
Diagnostics) and dilutions were used, which were found to cross- 
react with macaque antigens: MHC class II, mouse anti-human- 
HLA-DR (clone TAL.1BS),  t:50; mouse anti-human HLA-DR, 
DP,  DQ,  DX  (clone  CR3/43),  l:50; monocyte/macrophages, 
mouse anti-human CD68  (clones  KP1  and PG-M1),  1:50;  T 
lymphocytes,  rabbit, anti-human CD3  (polyclonal),  1:25;  and 
dendritic cells, rabbit anti-cow S-100  (polyclonal),  1:100.  The 
following dendritic cell antibodies were tested but failed to react 
with fixed-embedded macaque tissue: mouse anti-human CDIa 
(clone  010;  lmmunotech, Westbrook, ME), mouse anti-human 
B70/B7-2  (clone  1T209;  courtesy  of Ed  Engleman,  Stanford 
University, Stanford,  CA)  (29), and mouse anti-human F-actin 
(clone  55K2;  AIDS Research and Reference Reagent Program, 
NIAID, NIH) (30). When applicable, slides were counterstained 
with  Mayer's  hematoxylin  and  mounted  as  described  above. 
Controls  for  antibody  staining included  identically processed 
macaque spleen and lymph nodes. Hematoxylin and eosin stain- 
ing of slides was performed per standard protocols  (31). 
Results 
The First Cellular  Targets of SIV Infection Are Found in the 
Lamina Propria, Immediately Adjacent to the Epithelium.  To de- 
termine the first cellular target of SIV infection in the mu- 
cosa, we inoculated four female rhesus macaques intravagi- 
nally and atraumatically with a 70% animal infectious dose 
of SIVmac251  (23,  42,  43), and killed the animals 2,  5, 7, 
and 9 d later (designated Rh D2, Rh D5, Rh D7, and Rh 
D9,  respectively). An animal inoculated with heat-inacti- 
vated  SIVmac251  (Rh  HI)  in  an  identical  manner  and 
killed 2 d later, and an uninoculated animal (Rh Co) were 
used as controls. At necropsy, the vagina, cervix, spleen, and 
lymph nodes were harvested, fixed, and embedded in par- 
a~n blocks. To screen for the presence of SIV provirus in 
the  embedded tissue samples, cellular DNA was extracted 
and tested using a nested PCR for SIV gag. In this manner, 
we determined that vaginal tissues from all four inoculated 
animals contained provirus, whereas tissues from both con- 
trol animals did not. 
To identify the infected cells in the cervicovaginal mu- 
cosa, we subjected those tissue blocks found to contain SIV 
gag sequences by nested PCR to in situ PCR in the pres- 
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contained  amplifed  product  using  an  antibody  directed 
against digoxigenin (32, 33). Representative results are pre- 
sented in Fig.  1. Low-power magnification of the stratified 
squamous epithelium and the adjacent lamina propria from 
Rh D2  and Rh D5  are shown in Fig.  1, A  and B,  respec- 
tively.  We  found  many  SIV-infected  cells  in  the  lamina 
propria immediately subjacent to the epithelium, but none 
within  the  epithelium.  Similarly, SIV-infected  cells  were 
only found immediately beneath  the simple columnar epi- 
thelium of the endocervix of Rh D5  (Fig. 1  C). An identi- 
cal pattern of infection was demonstrable in all four experi- 
mental  animals.  Higher magnification  examination  of the 
vaginal  (Fig.  1,  D-F)  and  the  endocervical  (Fig.  1,  G--/) 
mucosa  confirmed  the  nested  PCR  results  that  SIV- 
infected cells were present in all four experimental animals. 
In  each  monkey,  SIV-infected cells were  abundant  in  the 
lamina  propria,  but  were  absent  in  the  overlying epithe- 
lium. Most SIV-infected cells were usually only a small dis- 
tance  (<25  b~m) away  from  the  basement  membrane, 
which separates the epithelium from the lamina propria. As 
the distance from the epithelial border increased, the num- 
ber of SIV-infected cells decreased dramatically. Occasional 
positive cells were  also found  deeper (not  shown),  on  the 
order  of hundreds  of microns  to  as  much  as  1  cm  away 
from the epithelial border. 
To  control for the specificity in detecting in situ PCR- 
amplified SIV gag DNA,  numerous controls were tested in 
parallel, and the results are shown in Fig. 2. These included 
tissues from control animals (Rh Co and Rh  HI; Fig. 2, A 
and B) and a block of tissue from Rh D5 that was found not 
to contain SIV by nested PCR  (Fig. 2  C). Nonspecific alka- 
line phosphatase staining was not observed (not shown). 
Morphology  and  Immunohistockemistry Suggest  that SIV- 
infected Cells Are Likely to be Dendritic Cells.  Upon close ex- 
amination, it became apparent that SIV-infected cells were 
morphologically diverse (Fig. 1). Although many cells were 
small and round, typical oflymphocytes, many were not. A 
sampling of the latter is shown  under higher magnification 
in  Fig.  3.  Their  size  and  morphology  suggest  that  many 
Figure  1.  Detection  of of SIV-infected 
cells in  the  mucosa of inoculated animals. 
Low magnification: (A) Rh D2, vagina; (/3) 
Rh  D5,  vagina; (C)  Rh  D5,  endocervix. 
Higher magnification, vagina: (D) Rh D2; 
(E) Rh D7; (F) Rh D9. Higher magnifica- 
tion, endocervix: (G) Rh D5;  (H) Rh D7; 
(0  Rh  D9.  Positive cells detected after in 
situ PCR  are indicated with  1", the  base- 
ment  membrane  with  A,  and  the  vaginal 
lumen  with  L.  Note  location  of infected 
cells in lamina propria, immediately adjacent 
to the epithelium, hut lack of positive cells 
in  the  epithelium itself. In situ PCR  was 
carried out in the presence of digoxigenin- 
dUTP, followed by incubation with alkaline 
phosphatase-conjugated  antidigoxigenin and 
NBT/BCIP  (see Materials and  Methods). 
The nuclei of positive cells stain black. The 
sections were counterstained with fast green 
and viewed  under  light microscopy. Bars: 
(A-C) 100 ~m; (D-I) 50 ~m. 
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Because  APC such as  dendritic  cells and  macrophages ex- 
press  CD4,  and  because  of the  potential  role  of dendritic 
cells in establishing a local, productive site for HIV-1 repli- 
cation (16, 34), we surmised that many of these larger non- 
lymphocytic cells  might be Langerhans dendritic  cells.  Al- 
though cellular morphology was maintained,  the extensive 
heat  treatment  and  proteinase  K  digestion  necessary  for 
PC1< destroyed the antigenic markers of the cells  we were 
interested  in  studying.  Therefore,  we  relied  on  studies  of 
serial,  contiguous (8-1xm)  sections. 
With  this  in  mind,  we  identified  infected  cells  after  in 
situ PCR as above in conjunction with performing immu- 
nohistochemistry  on  a  contiguous  section.  For  example, 
Fig. 4 A  shows SIV-infected cells detected by in situ  PCt/, 
in the vaginal lamina propria  of B.h D5,  and Fig.  4  B  de- 
picts  an  adjacent  section  stained  for MHC  class  II mole- 
cules. In this tissue, MHC  class II is expressed in high levels 
on APC and B  cells,  whereas activated T  cells  express only 
very low levels  of this antigen.  SIV-infected cells in many 
other tissue  sections correlated with MHC  class  II staining 
on contiguous sections and had long processes characteristic 
of APC.  To  specifically identify dendritic  cells,  we stained 
for the S-100 antigen,  which in mucosal tissue is found on 
dendritic  cells  and  cells  of neural  crest  origin.  As  another 
example,  Fig. 4  C shows an SIV-infected celt detected after 
in situ  PCP,.,  whereas  Fig.  4  D  shows an S-100 + cell with 
long processes in the same location on the adjacent section. 
Using this type of analysis, we were unable to detect mac- 
rophages  (cells  expressing  the  CD68  antigen)  that  were 
contiguous  to  SIV  infected  cells  (data  not  shown).  Al- 
though  our studies  are  obviously not  conclusive,  there  is 
evidence to suggest that nonlymphocytic cells  are targets of 
SIV infection in acute infection. 
Figure 2.  Controls  for detection of in situ 
PCR.-amphfied  product.  Typical sections 
showing lack of infected cells from: (A) R.h 
HI,  (/3) Rh  Co,  (C)  Rh D5,  tissue section 
negative by nested PCR. Sections were coun- 
terstained with fast green and viewed under 
light microscopy.  Of>40 controls mn in par- 
allel with samples (see Fig. 1),  positive cells 
were never detected. Bars, 100 ~m. 
Evidence for Focal Viral Spread and  Syncytia Formation in 
Deeper Mucosal Dendritic Cells.  In addition to positive cells 
found  near  the  epithelium,  we  found  occasional  SIV- 
infected cells  in the deeper tissue from each of the animals. 
An extreme example of this in P,.h D2 is shown in Fig. 5 A, 
representing  an  area  containing  a  nerve  ganglion  distant 
from the  epithelium.  The  neurons,  a's expected,  were  not 
infected  with  SIV.  However,  many cells  surrounding  the 
neurons were infected, and among these cells,  syncytia for- 
mation  was  evident.  Many  of the  positive  cells  are  large, 
with  elongated nuclei,  indicating that they are unlikely to 
be lymphocytes, but more likely to be APC (Fig. 5 A). 
To  test  this  assumption,  we stained  contiguous sections 
for MHC  class  II (Fig.  5,  B  and  C),  CD3  (T  cells;  Fig.  5 
C), and CD68 (macrophages; Fig. 5  D).  Many of the cells, 
having  processes  characteristic  of APC,  clearly  expressed 
MHC  class  II antigens.  There was virtually no staining for 
macrophages  (Fig.  5  D),  however,  and  only  a  few  cells 
stained  for CD3  (Fig.  5  C).  The morphology, staining for 
MHC class II, and lack of staining with anti-CD68 demon- 
strate  that  most of these  are  likely to  be  dendritic  cells  or 
dendritic  cell-T  cell  syncytia.  These  cells,  therefore,  are 
clearly  capable  of forming  syncytia and  spreading  SIV  to 
deeper mucosal tissues only a short time (2 d) after an intra- 
vaginal inoculation. 
Viral Dissemination Occurs through the Draining Lymphatics. 
To determine the route and time course of viral dissemina- 
tion  from the  mucosa,  we  obtained  the  draining  and  pe- 
ripheral lymph nodes from the animals at necropsy. In both 
humans  and macaques,  the lymphatic  drainage  of the  area 
to which  the  inoculum was applied,  the  upper two  thirds 
of the vagina,  the  cervix,  and the uterus,  is to the internal 
iliac lymph nodes, which are located along the internal iliac 
blood vessels,  deep within  the pelvis  (35).  To monitor the 
Figure  3.  High-power magnification of SIV-infected 
cells demonstrating nonlymphocytic morphology. Note 
elongated, irregular shaped, large cells (l')  and  their 
proximity to the basement membrane (A). Fast green 
counterstain. Tissue sections are from Rh D5 and R_h 
D7. Bars, 12.5 ~m. 
219  Spira et al. Figure 4.  Serial  section studies: SIV-infected  cells correlate with the lo- 
cation of APC and dendritic cells in the mucosa. Correlation of SIV- 
infected cells detected after in situ PCR with immunohistochemistry  per- 
formed on the contiguous (8-1xm) section. Cells infected with SIV and 
their corresponding  cells in contiguous sections are labeled  with A. Tis- 
sue sections are from Rh D5. (A and C) In situ PCR for SIV, fast green 
counterstain. Immunocytochemistry:  (B) MHC class II, section adjacent 
to A, hemaxtoxylin counterstain. (D) S-100, section adjacent to B, no 
counterstain. Cells expressing antigen are stained red with peroxidase/ 
3-amino-9-ethylcarbazole  (AEC). Bars, 50 txm. 
periphery for viral spread, we also obtained "nondraining" 
lymph nodes from the axillary and inguinal regions, as well 
as PBMC, splenic lymphocytes, and plasma. These samples 
were analyzed for the presence of SIV by culture (Table 1) 
and PCR (Table 2). Of all the samples tested, the only ones 
from which we were able to isolate virus by culture were 
from Rh D5. In this animal, terminal-bleed PBMC and the 
internal iliac lymph nodes (three of four tested)  contained 
infectious virus. None of the peripheral nodes from this an- 
imal were positive by culture (Table 1). 
PCR,  however,  demonstrated the presence of provirus 
throughout the  lymphatic tissues of all four experimental 
animals (Table  2);  control animals  (Rh  HI  and  Rh  Co) 
were  consistently negative. As  early as  2  d  after infection 
(Rh  D2),  the  draining (internal iliac)  lymph  nodes  con- 
tained provirus. The appearance of virus in the peripheral 
lymph nodes, however, was infrequent at day 2. In Rh D2, 
only one  of six peripheral lymph nodes  tested  contained 
provirus, whereas in Rh D5 and all later animals, many of 
the  peripheral  lymph  nodes  were  positive  for  provirus. 
From these results, we conclude that, within 2  d  of a mu- 
cosal inoculation, infected cells quickly disseminate virus to 
the draining lymph nodes. Once there, systemic dissemina- 
tion occurs shortly thereafter. 
The Internal  Iliac Lymph Nodes Demonstrate  a Low Level of 
Infected  Cells  in the  T  Cell-dependent Regions and the  Subcap- 
sular Sinus.  Because  of the  above observations, we  were 
interested in determining the frequency and location of in- 
fected cells in the  internal iliac lymph nodes.  To  do  this, 
we  detected  SIV-infected cells by in situ  PCR  in lymph 
nodes from Rh D5, which were found to contain SIV by 
both culture and nested PCR. Fig. 6 A  shows SIV-infected 
cells  from  one  such  lymph  node,  and  hematoxylin and 
eosin staining of an adjacent section (Fig. 6 B) demonstrates 
that  these  cells  localize  to  the  subcapsular  sinus  of  the 
lymph  node.  Infected  cells  were  also  localized  to  the  T 
Figure 5.  Evidence for the spread 
of infection in deep mucosal den- 
dritic cells by 2 d after vaginal  inocu- 
lation (Rh  D2). (A)  In sire PCR. 
Region shown is a nerve ganglion 
surrounded with SIV-infected cells. 
Note uninfected  neuron ({[) and for- 
mation of syncytia (it). Immunocy- 
tochemistry on  serial (8-hem) sec- 
tions:  (/3)  MHC  class  II  (red), 
peroxidase/AEC staining, hematox- 
ylin counterstain. (C)  CD3  (brown) 
and MHC class II (pink). MHC class 
II,  alkaline phosphastase-antialka- 
line  phosphatase/fast red  staining; 
CD3,  peroxidase/diaminobenzin- 
dine  staining, not  counterstained. 
(D) CD68 (red), stained  as in B. This 
area contains numerous MHC  class 
II-expressing cells, but virtually no 
macrophages or T cells, demonstrat- 
ing that a majority of the  infected 
cells in this area are dendritic cells. 
Bars, 50 btm. 
220  Vaginal Simian Immunodeficiency  Virus Transmission and Dissemination Table  1.  Ability to Isolate SIV by Culture 
Sample  Rh D2  Ikh D5  tkhD7  lkhD9  tkh HI 
PBMC 
Day 2 
Day 5 
Day 7 
Day 9 
Plasma 
Day 2 
Day 5 
Day 7 
Day 9 
Spleen 
Lymph Nodes 
Axillary 
Inguinal 
Paraaortic 
lliac 
m 
+  (3/4)* 
B 
w 
*  Three of four samples were positive; the negative sample was the most 
superior along the internal iliac artery. 
cell-dependent,  paracortical  zone  of the  draining  lymph 
node  (Fig.  6,  C  and  D).  In  no  case  were  infected  cells 
found in the germinal centers. A picture emerges to suggest 
that SIV-infected cells  migrate to the draining lymph node 
via the afferent lymphatics and enter the node through the 
subcapsular sinus.  From here,  these  cells  traverse  to the  T 
cell-dependent  areas  in  the  paracortical  regions  of  the 
nodes.  This  pathway  of migration  is  similar  to  that  de- 
scribed for the movement of tissue dendritic cells (36). 
Discussion 
In our model of a cell-free vaginal transmission,  the first 
SIV-infected cell was found in the lamina propria,  and not 
Table  2.  Ability to Detect SIV by PCR 
in the epithelium. As shown in Fig. 1, these cells are usually 
in immediate proximity to the basement membrane of the 
epithelium  and  are  found  in  high  numbers  in  both  the 
stratified  squamous  vagina/ectocervix  and  the  simple  co- 
lumnar endocervix.  It has been hypothesized by others  (2, 
15, 19, 37) that based on the known location ofCD4 + cells 
in the vaginal tract, the first cell to be infected would be an 
intraepithelial  Langerhans  cell.  In these  studies,  however, 
we  could find no  evidence  of infection in the  epithelium 
itself.  Studies in chronically infected animals have shown a 
much  broader,  including  intraepithelial,  presence  of SIV- 
infected  cells  (19,  20),  thereby  countering arguments  that 
the  infected cells  we find are  the  result of secondary viral 
replication. 
This multilayered  epithelium  may act as a physical bar- 
tier to repel most of the invading virus, and it is only those 
few viral particles that are able to penetrate  into the lamina 
propria  that  can initiate  an infection.  How does the  virus 
make  it  through  the  epithelial  barrier?  The  stratified  epi- 
thelium of the vagina is not the tight, impenetrable  barrier 
of the  skin.  Although  aglandular,  it  is  moist,  and  fluid  is 
continuously passing  through  the  intercellular  space  from 
the  lamina  propria.  Epithelial  cells  are  connected  by dis- 
continuous  patches  of desmosomes,  the  weakest  form  of 
intercellular junction. This, at best, keeps the cellular mem- 
branes 30 nm apart (38). Although still  significantly smaller 
than a retroviral particle  (100--150 nm), it is possible that a 
small fraction of the viruses in the inoculum may be able to 
permeate through the entire epithelium to the lamina pro- 
pria.  Another  possibility  is  that  the  virus  may  bind  to 
Langerhans cells  in the epithelium without infecting them, 
as has been shown to happen in the case of blood-derived 
dendritic  cells  (16).  These virus-bound cells,  which would 
not be detected by our in situ  PCR  to detect  SIV DNA, 
could then  migrate  to  the lamina propria  and  there  infect 
the first CD4-positive cell encountered.  Although not ob- 
served  macroscopically  or  microscopically,  there  may  be 
some  disruption  in  the  integrity  of the  epithelium  at  the 
time  of inoculation,  which would permit  passage of some 
virus  to  the  lamina propria.  Lastly,  though  not present  in 
the  vagina,  M  cells  in  the  intestine  have  been  shown  to 
Sample  IKh D2  1Kh D5  Rh D7  tKh D9  Rh HI  Kh Co 
PBMC 
Day 2 
Day 5 
Day 7 
Day 9 
Spleen 
Lymph Nodes 
Internal iliac 
Axillary 
Inguinal 
+  +  + 
m 
+ 
+  (3/4)  +  (4/7)  +  (1/1)  +  (3/5) 
+ (1/2)  +  (3/7)  +  (2/4)  +  (4/8) 
--  (0/4)  +  (2/6)  +  (2/3)  +  (2/3) 
w 
221  Spira et al. Figure 6.  Localization of infected cells in the drain- 
ing lymph nodes in P,h D5. Cells infected with SIV are 
labeled with  1.  (A) In situ PCK,  fast green counter- 
stain. This section represents the subcapsular sinus of 
the lymph node delineated by the brackets shown in B; 
hematoxylin and eosin stain. (C)  In situ PCt<.  This 
section represents the T  cell-dependent  region (para- 
cortical zone) of the  lymph  node  delineated by the 
brackets shown in  D;  hematoxylin  and  eosin stain. 
Controls identical to those in Fig. 2 were run in paral- 
lel. Dark spots not labelled are hemogloblin debris from 
necropsy. Bars: (A and C) 100 p,m; (B and D) 250 Ixm. 
carry virus across the  epithelium  (39),  so  a  similar, as yet 
undefined mechanism may be operative in the vaginal mu- 
cosa. Despite these possibilities, we cannot yet definitively 
determine how SIV crossed the epithelium. 
It is possible that for transmission to  occur,  transport of 
virus across the epithelium (columnar or squamous)  to the 
lamina propria is indeed a  limiting factor in infection effi- 
ciency.  Viruses  such  as  poliovirus,  herpesvirus,  and  rhi- 
novirus have been  shown  to  directly infect epithelial cells 
(40),  which may explain why these viruses are more  easily 
transmitted  than  HIV.  It  might  be  expected  that  passage 
through  a  single layer of epithelial cells to the lamina pro- 
pria--as in the  endocervix (Fig. 2)--is far easier than pas- 
sage  through  multiple layers. Histologically, the  rectum  is 
similar to  the  endocervix, with a  simple columnar epithe- 
lium.  Based  on  our  observations,  we  hypothesize  that  at 
least some of the increased risk of HIV-1  transmission asso- 
ciated with  anal intercourse  is due  to  this thinner  epithe- 
lium.  Although  the  endocervical epithelium is simple co- 
lumnar,  physical barriers such as the high levels of mucous 
present at the external os, combined with its limited acces- 
sibility and relatively small surface area, may greatly reduce 
the exposure of this tissue to virus. 
As  described  previously  (3,  7),  sexual  transmission  of 
HIV-1  appears  to  be  selective in  that  certain  minor viral 
variants from the infecting mixtures of viruses are preferen- 
tially transmitted.  We  now  provide  evidence  that  cells in 
the  lamina  propria  of the  cervicovaginal mucosa  that  re- 
semble  dendritic  cells  may  play  a  role  in  the  selection 
mechanism.  Because  of  the  known  diversity  of  HIV-1 
functional phenotypes, it may be that certain viral variants 
infect  the  mucosal  dendritic  cell  with  greater  efficiency, 
leading to establishment of infection by those variants. This 
underscores the importance of developing vaccines against 
primary HIV-1  isolates found in  recently infected persons 
rather than against laboratory strains. 
Trafficking of lymphocytes and APC  has been well de- 
fined. From mucosal sites, primarily APC but also lympho- 
cytes migrate into the afferent lymphatics. From there, they 
enter  the  lymph  nodes  through  the  subcapsular sinus  and 
traverse toward the T  cell areas in the paracortical regions. 
Whereas  APC  terminate  here,  lymphocytes  can  leave 
through  the  efferent  lymphatics,  enter  the  thoracic  duct, 
and spread hematogenously. This is precisely the same mi- 
gration pattern we have observed for SIV spread, which is 
schematically summarized in Fig. 7.  The first targets of in- 
Figure 7.  Model for mucosal transmission  of SIV and HIV. See text for 
the discussion. Dendritic cells are shown in green, macrophages in red, 
lymphocytes in blue, and virus in grey. 
222  Vaginal Simian lmmunodeficiency Virus Transmission  and Dissemination fection were found in the lamina propria, and we also ob- 
served local spread within the mucosa itself. Within 2  d  of 
inoculation,  infected  cells  have  migrated  to  the  draining 
lymph nodes, which appear to be a major site of viral repli- 
cation.  After deposition and  replication of virus  in  the  T 
cell-dependent  regions  of the  lymph  nodes  (Fig.  6),  in- 
fected T  cells and free virus can leave through the efferent 
lymphatics and disseminate widely. We can only speculate 
that sexual transmission of HIV-1 follows a similar pathway. 
It is significant that despite the presence ofCD4 § cells in 
the epithelium (19,  20), we were unable to detect infected 
cells there.  It has been reported that the best milieu for in- 
fection by HIV-1 in vitro is conjugates oflymphocytes and 
dendritic cells (34).  In uninfected animals, we have  found 
many more dendritic cells in the lamina propria than in the 
epithelium itself, and it is possible that the former is the op- 
timal milieu  for  efficient  infection.  An  infected  dendritic 
cell can present the virus to many T  cells in the nmcosa or 
after trafficking to the lymph nodes, resulting in substantial 
amplification of the virus.  In the lamina propria of the co- 
lonic mucosa,  it is also the  dendritic cell that is the major 
APC, and the primary means by which T  cells are activated 
(41). It might be expected that any factor that results in in- 
creased  antigen  presentation  at  the  time  of transmission, 
such as a concomitant infection, could result in more effi- 
cient viral spread. Although our studies cannot definitively 
identify the infected cell population, the cells that are SIV- 
infected  are  in  regions  (Figs.  4  and  5)  that  contain  large 
numbers  of MHC  class II +  and  S-100 -~ cells, and are thus 
likely to be dendritic cells. 
Whereas in previous studies a  single dose of the inocu- 
lum we used has led to culturable viremia in only 70%  of 
animals inoculated intravaginally (42, 43),  100% of the four 
experimental animals  in  this  study  demonstrated  infected 
cells at the site of inoculation, in the draining lymph nodes, 
and  in  the  peripheral lymphoid tissue.  Because  these  ani- 
mals were killed early, aside from Rh D5, it is impossible to 
say which  animals would have  developed an  obvious dis- 
seminated  infection  (Table  1).  Studies  to  determine  if a 
limited mucosal infection can occur without systemic dis- 
semination are underway.  This may also be relevant to the 
phenomenon  of transient  infections,  previously  noted  in 
macaques inoculated intravaginally (44). 
Our  findings on  the  mucosal transmission  of SIV  have 
important implications for vaccine development. A  vaccine 
must  induce  immune  responses  that  effectively block  at 
least one of the steps in the earliest stages of infection. One 
way to protect is via mucosal antibodies that neutralize vi- 
rus before it infects its initial target cell in the lamina pro- 
pria. In addition, throughout the vaginal mucosa of normal 
animals lie a  large number  of CD8 +  lymphocytes (2,  20), 
which  could  destroy  cells  that  become  productively  in- 
fected with virus. Furthermore, because of the importance 
of the draining lymphatics in viral dissemination, it nfight 
be expected that a specific antiviral immune response here 
would be  extremely effective in preventing  the  establish- 
ment of infection. In future studies, it would be interesting 
to examine the steps in SIV transmission and spread that are 
blocked by an efficacious vaccine, such as the live attenu- 
ated virus (45). 
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